Some Oestrogen-Negative Breast Cancer Patients May Benefit From Prostate Cancer Therapy
6/24/2011
Cancer Research UK scientists have discovered why a sub group of oestrogen-receptor-negative breast cancer patients could benefit from prostate cancer treatments which target the cell's androgen receptor - a key driver of prostate cancer, according to research published in The EMBO Journal today...
Arno Therapeutics, Inc. (OTCBB: ARNI) announced today that its Phase II clinical study of AR-67 has met pre-defined interim goals for patients with glioblastoma multiforme (GBM) who were not previously treated with Avastin® and will continue toward completion. AR-67 is a novel, third-generation camptothecin analogue that inhibits Topoisomerase I activity...
New Breast Cancer Risk Model Quantifies The Impact Of Risk Reduction
6/24/2011
How much can a woman lower her risk of breast cancer by losing weight, drinking less, or exercising more? A study published online June 24 in the Journal of the National Cancer Institute describes a new model to estimate the impact of these lifestyle changes on absolute breast cancer risk, suggesting risk reductions that could translate into a substantial number of prevented ca...
CEL-SCI Announces Start Of Multikine Phase III Study By Orient Europharma In Taiwan
6/24/2011
CEL-SCI Corporation (NYSE AMEX: CVM) announced today that its Taiwanese partner, Orient Europharma, has concluded the Site Initiation Visit for the first Taiwanese clinical center in CEL-SCI's Phase III clinical trial for Multikine®, the Company's flagship cancer immunotherapy. The first center is called Shin Kong Wu Ho-Su Memorial Hospital and is located in Taipei, Taiwan...
Millennium: The Takeda Oncology Company today announced the presentation of results from an ongoing Phase II study of MLN8237, an investigational Aurora A kinase inhibitor, in patients with relapsed/refractory aggressive B-cell and T-cell non-Hodgkin lymphoma (NHL)...
Scientists from the Genome Institute of Singapore (GIS), an institute of the Agency for Science, Technology and Research (A*STAR), in collaboration with the Cancer Science Institute of Singapore (CSI), have discovered how the body uses a single communication system to decide the fate of stem cells...
Dr Frank McKeon, Senior Group Leader of the Stem Cell and Developmental Biology at A*STAR's Genome Institute of Singapore (GIS), and Principal Investigator Dr Wa Xian at A*STAR's Institute of Medical Biology (IMB), together with their counterparts from the Harvard Medical School, the Brigham and Women's Hospital in Boston, and the National University of Singapore, have made the...
New Online Training Assists GPs With Cancer Screening, Australia
6/24/2011
A new interactive online educational activity on cancer screening has been released to assist GPs...
Rates Of US Mammography Screening Improved By Community Health Worker Interventions
6/24/2011
Education, referrals, support and other interventions by community health workers improve rates of screening mammography in the United States - especially in medical and urban settings and among women whose race and ethnicity is similar to that of the community health workers serving them...
The Journal Of Clinical Investigation: June 23, 2011
6/24/2011
PULMONARY: New cell population repairs the damaged lung A team of researchers, led by Harold Chapman and Thiennu Vu, at the University of California San Francisco, San Francisco, has identified a previously unrecognized population of cells in the lungs of mice (alveolar epithelial cells expressing alpha-6-beta-4) and determined that these cells serve as multipotent progeni...